MoneyWorks4Me

The company witnessed a 5.56% growth in the revenue at Rs. 594.89 millions for the quarter ended September 2021 as compared to Rs. 563.53 millions during the year-ago period.The Profit  for the quarter ended September 2021 of  Rs. 73.08  millions  grew by 82.38% from Rs. 40.07 millions.Operating profit for the quarter ended September 2021 rose to 105.66 millions as compared to 52.47 millions of corresponding quarter ended September 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 594.89 563.53 5.56 1194.88 880.05 35.77 1879.46 1585.68 18.53
Other Income 2.85 4.14 -31.16 11.07 11.98 -7.60 43.93 25.26 73.91
PBIDT 105.66 52.47 101.37 206.62 86.77 138.12 234.72 110.59 112.24
Interest 0.63 1.17 -46.15 1.68 2.48 -32.26 5.14 5.14 0.00
PBDT 105.03 51.30 104.74 204.94 84.29 143.14 229.58 105.45 117.71
Depreciation 2.28 2.75 -17.09 5.11 5.50 -7.09 10.86 11.30 -3.89
PBT 102.75 48.55 111.64 199.83 78.79 153.62 218.72 94.15 132.31
TAX 29.67 8.48 249.88 58.26 13.53 330.60 48.14 15.44 211.79
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 73.08 40.07 82.38 141.57 65.26 116.93 170.58 78.71 116.72
Equity 130.99 130.99 0.00 130.99 130.99 0.00 130.99 130.99 0.00
PBIDTM(%) 17.76 9.31 90.76 17.29 9.86 75.38 12.49 6.97 79.07
Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..